|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/195 | |
| A61K 47/00 | |||
| A61L 9/04 | |||
| A61K 47/02 | |||
| A61K 9/00 | |||
| A61K 31/197 | |||
| A61K 31/192 |
| (11) | Number of the document | 2167071 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08770940.8 |
| Date of filing the European patent application | 2008-06-13 | |
| (97) | Date of publication of the European application | 2010-03-31 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/066831 |
| Date | 2008-06-13 |
| (87) | Number | WO 2008/157288 |
| Date | 2008-12-24 |
| (30) | Number | Date | Country code |
| 943729 P | 2007-06-13 | US |
| (72) |
MEYTHALER, Jay, M., US
TUEL, Stephen, M., US
|
| (73) |
Wayne State University Board Of Governors,
656 W. Kirby, Detroit, MI 48202,
US
Phase V. Pharmaceuticals, Inc., 2139 Darcy Green Place, Silver Spring, MD 20910, US |
| (54) | A BACLOFEN SOLUTION FOR LOW-VOLUME THERAPEUTIC DELIVERY |
| A BACLOFEN SOLUTION FOR LOW-VOLUME THERAPEUTIC DELIVERY |